Sign in
4

Changes in Ownership

Arcturus Therapeutics Holdings Inc. Filed Acc 0000899243-20-005386

Options or other derivatives

  • Chief Development Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hughes Steven George Chief Development Officer 2020-02-18 Grant or award · Stock Option (right to buy) +75,000 75,000 D
Loading xslF345X03/doc4.xml…